Scholarly Index
Joyce O’Shaughnessy
Baylor University Medical Center; 22,052 total citations; 521 total publications; best world rank #32
Baylor University Medical Center
22,052Total citations
521Total publications
69H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Treatment and Pharmacology | Lifetime | 206 | US 114 | 99.37 |
| Breast Cancer Treatment Studies | Lifetime | 223 | US 115 | 99.25 |
| Advanced Breast Cancer Therapies | Lifetime | 95 | US 48 | 99.12 |
| HER2/EGFR in Cancer Research | Lifetime | 195 | US 95 | 99.10 |
| Colorectal Cancer Treatments and Studies | Lifetime | 917 | US 354 | 97.44 |
| Chemotherapy-related skin toxicity | Lifetime | 123 | US 66 | 95.38 |
| PARP inhibition in cancer therapy | Lifetime | 419 | US 200 | 95.26 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 782 | US 329 | 88.84 |
| Breast Cancer Treatment Studies | 2021-2025 | 37 | US 16 | 99.48 |
| Advanced Breast Cancer Therapies | 2021-2025 | 32 | US 12 | 99.37 |
| Cancer Treatment and Pharmacology | 2021-2025 | 39 | US 15 | 99.11 |
| HER2/EGFR in Cancer Research | 2021-2025 | 46 | US 17 | 99.17 |
| Cancer-related Molecular Pathways | 2021-2025 | 146 | US 66 | 91.81 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 823 | US 339 | 92.20 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 883 | US 280 | 89.51 |
| Estrogen and related hormone effects | 2021-2025 | 894 | US 264 | 71.50 |